Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance
M Kusztal, R Kłak, M Krajewska, M Boratyńska… - Transplantation …, 2011 - Elsevier
BACKGROUND: Extracorporeal photopheresis (ECP) is considered to be a promising
immunomodulatory therapy in diseases caused by aberrant T lymphocytes. ECP has been …
immunomodulatory therapy in diseases caused by aberrant T lymphocytes. ECP has been …
[引用][C] Blood prime for patients with single‐needle access requiring extracorporeal photopheresis: How to do and why it may be useful
MN Boshell, DB Peavey, SC Simmons… - Journal of Clinical …, 2018 - Wiley Online Library
Extracorporeal photopheresis (ECP) is an immunomodulation procedure that may be used
as an adjunct therapy in patients with cutaneous T cell leukemia/lymphoma, graftversus-host …
as an adjunct therapy in patients with cutaneous T cell leukemia/lymphoma, graftversus-host …
[HTML][HTML] Collection efficiency of mononuclear cells in offline extracorporeal photopheresis: can processing time be shortened?
O Kartal, N Lindlbauer, S Laner-Plamberger… - Blood …, 2024 - ncbi.nlm.nih.gov
Background Extracorporeal photopheresis (ECP) is a well-established but lengthy and
burdensome cell-based therapy for various diseases such as cutaneous T-cell lymphoma …
burdensome cell-based therapy for various diseases such as cutaneous T-cell lymphoma …
Update on extracorporeal photopheresis
U Just, R Knobler - Der Hautarzt, 2015 - Springer
Bei der extrakorporalen Photopherese (ECP) handelt sich um ein von der PUVA-Therapie
abgeleitetes Therapiekonzept, das Leukapherese mit der Photochemotherapie verbindet …
abgeleitetes Therapiekonzept, das Leukapherese mit der Photochemotherapie verbindet …
Best practice recommendations in:(1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal …
P Perseghin, M Marchetti, C Messina… - … and Apheresis Science, 2013 - trasci.com
2. Methods Two distinct panels of experts met several times from 2010 to 2011 to address
the PBSC-related issues (components: PP, MM, CM, LS, MR, FR, PA, LP and BA) and those …
the PBSC-related issues (components: PP, MM, CM, LS, MR, FR, PA, LP and BA) and those …
Iron deficiency anemia associated with extracorporeal photopheresis: a retrospective analysis
AK Kuhn, GT Bartoo, RA Dierkhising… - Journal of Clinical …, 2019 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) is associated with few adverse effects. We
have anecdotally noted patients treated with long‐term ECP develop iron deficiency anemia …
have anecdotally noted patients treated with long‐term ECP develop iron deficiency anemia …
Extracorporeal photopheresis: past, present, and future
R Knobler, ML Barr, DR Couriel, JLM Ferrara… - Journal of the American …, 2009 - Elsevier
Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …
Miscellaneous indications for extracorporeal photochemotherapy (ECP)
H Andreu-Ullrich - Transfusion and Apheresis Science, 2014 - Elsevier
Extracorporeal photochemotherapy (ECP) has been applied to many T-cell mediated
diseases where immunosuppressive drugs are insufficient or not tolerated. As ECP is mainly …
diseases where immunosuppressive drugs are insufficient or not tolerated. As ECP is mainly …
Use of extracorporeal photopheresis in scleroderma: a review
AX Du, M Osman, R Gniadecki - Dermatology, 2020 - karger.com
Background: Scleroderma is a heterogeneous group of diseases that can be localized or
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …
[DOC][DOC] For the listing of integrated, closed-system ECP systems
DAPDA Protocol, MBSMB Schedule, PBSPB Scheme - msac.gov.au
PBAC Submission Application Number 1420 to the Medical Services Advisory Committee For
the listing of integrated, closed-system ECP systems For the treatment of acute and chronic …
the listing of integrated, closed-system ECP systems For the treatment of acute and chronic …